Saturn V Capital Management »

Enliven Therapeutics shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.6M 152k 23.37